Bone Density Testing Low in Veterans With Kidney Stone Disease
WEDNESDAY, March 3, 2021 -- Almost one-quarter of patients with kidney stone disease have a prevalent diagnosis of osteoporosis or fracture, and screening after diagnosis identifies additional patients with osteoporosis, according to a study published online March 3 in the Journal of Bone and Mineral Research.
Calyani Ganesan, M.D., of Stanford University in California, and colleagues conducted a retrospective cohort study to examine the prevalence of osteoporosis and fractures and rate of bone mineral density screening by dual-energy X-ray absorptiometry (DXA) using data from the Veterans Health Administration. A total of 531,431 patients were identified with kidney stone disease between 2007 and 2015.
The researchers found that 23.6 percent of patients with kidney stone disease had a prevalent diagnosis of osteoporosis or fracture. Of those with no previous history of osteoporosis or bone mineral density assessment before diagnosis, 9.1 percent of patients were screened with DXA after a diagnosis of kidney stone; 20 percent of these patients were then diagnosed with osteoporosis.
"We hope this work raises awareness regarding the possibility of reduced bone strength in patients with kidney stones," Ganesan said in a statement. "In our future work, we hope to identify which patients with kidney stones are at higher risk for osteoporosis or fracture to help guide bone density screening efforts by clinicians in this population."
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
TUESDAY, April 13, 2021 -- Reimbursement for hospital charges is increasing faster than payments for surgeons performing hip fracture surgeries on Medicare beneficiaries,...
WEDNESDAY, March 31, 2021 -- The age-adjusted prevalence of osteoporosis at either the femur neck or lumbar spine or both was 12.6 percent among adults aged 50 years and older in...
MONDAY, March 29, 2021 -- In new joint guidelines issued by bone health experts, recommendations are presented for managing osteoporosis therapy in the context of COVID-19...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.